Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Baxter
Federal Trade Commission
Farmers Insurance
Colorcon
Boehringer Ingelheim
Cantor Fitzgerald
Daiichi Sankyo
Merck

Generated: July 19, 2018

DrugPatentWatch Database Preview

Methyprylon - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for methyprylon and what is the scope of methyprylon freedom to operate?

Methyprylon
is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for methyprylon
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 12
Patent Applications: 1,205
DailyMed Link:methyprylon at DailyMed
Synonyms for methyprylon
(?)-Noludar
(+)-Noludar
125-64-4
2, 3,3-diethyl-5-methyl-
2,3-diethyl-5-methylpiperidine
2,4-Dioxo-3,3-diethyl-5-methylpiperidine
2,4-Dioxy-3,3-diethyl-5-methylpiperidine
2,4-Piperidinedione, 3,3-diethyl-5-methyl-
3,3-Diethyl-2,4-dioxo-5-methylpiperidine
3,3-Diethyl-5-methyl-2,4-piperidinedione
3,3-Diethyl-5-methylpiperidine-2,4-dione
3,4-dioxo-5-methylpiperidine
5,5-diethyl-6-hydroxy-3-methyl-2,3,4,5-tetrahydropyridin-4-one
AC1L1HJV
ACM125644
AKOS006239549
BRN 0082860
C10H17NO2
CHEBI:31837
CHEMBL1200790
D01150
D05OQJ
DB01107
DEA No. 2575
Dimerin
DTXSID7023306
EINECS 204-745-4
FCH834496
GTPL7238
HE039380
HE303875
HSDB 3128
LS-115204
Methprylon
Methyprolon
Methyprylon (JAN/INN)
Methyprylon [INN]
Methyprylone
Methyprylone [INN-French]
Methyprylonum
Methyprylonum [INN-Latin]
Metiprilon
Metiprilona
Metiprilona [INN-Spanish]
Metiprilone
Noctan
Nodular
Noludar
Noludar (TN)
NSC 30442
NSC-30442
NSC30442
Ro 1-6463
SCHEMBL155838
SIDLZWOQUZRBRU-UHFFFAOYSA-N
WLN: T6MV DVTJ C2 C2 E1

US Patents and Regulatory Information for methyprylon

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche NOLUDAR methyprylon TABLET;ORAL 009660-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche NOLUDAR methyprylon ELIXIR;ORAL 009660-007 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche NOLUDAR methyprylon TABLET;ORAL 009660-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche NOLUDAR methyprylon CAPSULE;ORAL 009660-008 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
Chinese Patent Office
Moodys
Harvard Business School
Farmers Insurance
Boehringer Ingelheim
Cipla
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.